NCT00175825 - A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures. | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

November 7, 2005

Primary Completion Date

June 29, 2006

Study Completion Date

June 29, 2006

Conditions

Epilepsy

Interventions

OTHER

Placebo

Daily oral dose of two equal intakes, morning and evening, of Placebo in a double-blinded way for the 7-week Treatment Period

DRUG

Brivaracetam

Daily oral dose of two equal intakes, morning and evening, of Brivaracetam over the 7-week Treatment Period

Trial Locations (42)

Unknown

Phoenix

Little Rock

Fresno

Bradenton

Jacksonville

Chicago

Paducah

Ruston

Bethesda

Burlington

Grand Rapids

Rochester

Tupelo

Chesterfield

Great Falls

Englewood Cliffs

Toms River

New York

Wilmington

Columbus

Philadelphia

Woonsocket

Greenville

Dallas

Houston

Salt Lake City

Florianópolis

Salvador

São Paulo

Bangalore

Hyderabad

Lucknow

Parel Mumbai

Trivandrum

Aguascalientes

Chichuahua

Chihuahua City

Guadalajara

Monterrey

San Luis Potosí City

Valle Oriente Garza Garcia

Zapopan